Cite
HARVARD Citation
TeBay, C. et al. (2022). Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation. British journal of pharmacology. pp. 2631-2646. [Online].